Bioelectronic Therapy Device Exercises Heart Muscle
|
By HospiMedica International staff writers Posted on 22 Jul 2019 |
|
Image: The implanted device is designed to stimulate cell regeneration in cardiomyopathy (Photo courtesy of Berlin Heals).
A novel electroceutical device readjusts the myocardial electrical gradient in order to strengthen the weakened heart muscle of cardiomyopathy patients.
Under development by Berlin Heals (Berlin, Germany), C-MIC cardiac microcurrent therapy is based on an implanted pulse generator that exercises the heart muscle using electricity, thus stimulating it to renew itself. In a minimally invasive procedure, a small microcurrent pulse generator is implanted via two small incisions. Two electrodes exit the pulse generator, one taking the form of an extensive patch on the outside of the heart muscle, while the other is placed inside the left ventricle. The system is designed to stimulate the affected heart muscle, causing it to regenerate.
In a preclinical study at Hannover Medical School (Germany) involving 12 sheep with chronic systolic heart failure, the continuous microcurrent therapy was associated with a strong improvement of left ventricular ejection fraction (LVEF), indicating reversal of cardiac remodeling and reduced myocardial inflammation. A first in human study of the C-MIC device at the Medical University of Vienna (MedUni; Austria) revealed that after three months, the first patient treated showing initial signs of regeneration. The study was published in the April 2019 issue of The Journal of Heart and Lung Transplantation.
“The preliminary findings bring us real hope for cardiomyopathy patients. Microcurrent regeneration could bring us a step closer to the dream of being able to regenerate damaged organs,” said lead author Dominik Wiedemann, MD, of the MedUni division of cardiac surgery. “Particularly in times when donor organs are scarce, it is important to develop new effective treatment techniques to avoid major operations such as heart transplants as much as possible, as well as the subsequent immunosuppression that goes with them."
In dilative cardiomyopathy, the heart muscle becomes pathologically enlarged so that it can no longer contract sufficiently. Current treatments attempt to stabilize such heart failure patients for as long as possible by means of optimized drug treatment or specialized pacemakers. The treatment of last resort for terminal heart failure is a heart transplant or mechanical replacement using a left ventricular assist device (LVAD).
Related Links:
Berlin Heals
Hannover Medical School
Medical University of Vienna
Under development by Berlin Heals (Berlin, Germany), C-MIC cardiac microcurrent therapy is based on an implanted pulse generator that exercises the heart muscle using electricity, thus stimulating it to renew itself. In a minimally invasive procedure, a small microcurrent pulse generator is implanted via two small incisions. Two electrodes exit the pulse generator, one taking the form of an extensive patch on the outside of the heart muscle, while the other is placed inside the left ventricle. The system is designed to stimulate the affected heart muscle, causing it to regenerate.
In a preclinical study at Hannover Medical School (Germany) involving 12 sheep with chronic systolic heart failure, the continuous microcurrent therapy was associated with a strong improvement of left ventricular ejection fraction (LVEF), indicating reversal of cardiac remodeling and reduced myocardial inflammation. A first in human study of the C-MIC device at the Medical University of Vienna (MedUni; Austria) revealed that after three months, the first patient treated showing initial signs of regeneration. The study was published in the April 2019 issue of The Journal of Heart and Lung Transplantation.
“The preliminary findings bring us real hope for cardiomyopathy patients. Microcurrent regeneration could bring us a step closer to the dream of being able to regenerate damaged organs,” said lead author Dominik Wiedemann, MD, of the MedUni division of cardiac surgery. “Particularly in times when donor organs are scarce, it is important to develop new effective treatment techniques to avoid major operations such as heart transplants as much as possible, as well as the subsequent immunosuppression that goes with them."
In dilative cardiomyopathy, the heart muscle becomes pathologically enlarged so that it can no longer contract sufficiently. Current treatments attempt to stabilize such heart failure patients for as long as possible by means of optimized drug treatment or specialized pacemakers. The treatment of last resort for terminal heart failure is a heart transplant or mechanical replacement using a left ventricular assist device (LVAD).
Related Links:
Berlin Heals
Hannover Medical School
Medical University of Vienna
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
High-Precision QA Tool
DEXA Phantom
New
Endoscopy Display
E190
Latest Critical Care News
- Implantable Device Could Save Diabetes Patients from Dangerously Low Blood Sugar
- New Prostate Screening Device Could Replace Traditional Examination Method
- Adaptive Spine Board to Revolutionize ER Transport
- Mapping Communication Between Internal Organs to Enable Earlier Illness Diagnosis
- Intelligent Wound Dressing Reduces Inflammation and Promotes Healing
- Cuff-Free Blood Pressure Monitoring Device to Improve Early Detection and Management of Hypertension
- New Understanding of Barrett’s Esophagus Formation to Enable Earlier Intervention and Diagnosis
- 3D Printed Functional Human Islets Could Transform Type 1 Diabetes Treatment
- AI Model Predicts ICU mortality in Heart Failure Patients
- Smart Capsule Offers Real-Time Profiling Across GI Tract
- Ultra-Thin Implant Helps Patients with Spinal Cord Injury Recover Lost Functions
- Portable Cell Therapy Device to Enable Rapid On-Demand Modification of RBCs at POC
- Monitoring Airborne Fungal Spores Could Help Predict COVID-19 & Flu Surges
- New System Measures Blood Sodium Without Needles
- Sleep Data from Wearable Device May Help Predict Preterm Birth
- AI Tool Interprets Echocardiograms in Minutes
Channels
Surgical Techniques
view channel
Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery
Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more
LED-Based Imaging System Could Transform Cancer Detection in Endoscopy
Gastrointestinal cancers remain one of the most common and challenging forms of cancer to diagnose accurately. Despite the widespread use of endoscopy for screening and diagnosis, the procedure still misses... Read more
Patient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read more
Business
view channel
Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
